Molecular Pharmaceutics This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

[ASAP] The Transition from Academia to Industry as an Early Career Scientist: The Why, the How, and the What
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00109 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 15, 2023 Category: Drugs & Pharmacology Authors: Hoda Soleymani Abyaneh Source Type: research

[ASAP] Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat Liver and Intestinal Segments for Applications in PBPK Modeling
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00950 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 15, 2023 Category: Drugs & Pharmacology Authors: Sheena Sharma, Dilip K. Singh, Vijay S. Mettu, Guihua Yue, Deepak Ahire, Abdul Basit, Scott Heyward, and Bhagwat Prasad Source Type: research

[ASAP] Minimization of Acid-Catalyzed Degradation in KinetiSol Processing through HPMCAS Neutralization
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00791 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 14, 2023 Category: Drugs & Pharmacology Authors: Isaac Corum, Angela Spangenberg, Krystal Miller, Sandra Kucera, and Dave Miller Source Type: research

[ASAP] Characterization of PGua < sub > 4 < /sub > , a Guanidinium-Rich Peptoid that Delivers IgGs to the Cytosol via Macropinocytosis
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00783 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 13, 2023 Category: Drugs & Pharmacology Authors: Andre ́anne Laniel, Étienne Marouseau, Duc Tai Nguyen, Ulrike Froehlich, Claire McCartney, Pierre-Luc Boudreault, and Christine Lavoie Source Type: research

[ASAP] Functional Characterization of Six < italic toggle="yes" > SLCO1B1 < /italic > (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00715 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 13, 2023 Category: Drugs & Pharmacology Authors: Katja Ha ̈kkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman⧫, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Source Type: research

[ASAP] Enhancing Methotrexate Delivery in the Brain by Mesoporous Silica Nanoparticles Functionalized with Cell-Penetrating Peptide using < italic toggle="yes" > in Vivo < /italic > and < italic toggle="yes" > ex Vivo < /italic > Monitoring
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00755 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 10, 2023 Category: Drugs & Pharmacology Authors: Nasim Shadmani, Pooyan Makvandi, Maliheh Parsa, Amir Azadi, Keivan Nedaei, Negin Mozafari, Narges Poursina, Virgilio Mattoli ×, Franklin R. Tay◇, Aziz Maleki, and Mehrdad Hamidi Source Type: research

[ASAP] Theoretical and Experimental Investigation of Autoxidation Propensity of Selected Drugs in Solution State
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00967 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 9, 2023 Category: Drugs & Pharmacology Authors: Jayant Iyer, Michael Brunsteiner, Andrew Ray, Adrian Davis, Isha Saraf, and Amrit Paudel Source Type: research

[ASAP] Impact of Crystal Nuclei on Dissolution of Amorphous Drugs
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00989 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 7, 2023 Category: Drugs & Pharmacology Authors: Xin Yao, Lian Yu, and Geoff G. Z. Zhang Source Type: research

[ASAP] Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: < italic toggle="yes" > Ex Vivo < /italic > and < italic toggle="yes" > In Vivo < /italic > Evaluations
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00943 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 6, 2023 Category: Drugs & Pharmacology Authors: Maie S. Taha, Shallu Kutlehria, Anisha D ’Souza, Benjamin S. Bleier, and Mansoor M. Amiji Source Type: research

[ASAP] Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00962 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 6, 2023 Category: Drugs & Pharmacology Authors: Elena Di Lascio, Gre ́gori Gerebtzoff, and Raquel Rodríguez-Pérez Source Type: research

[ASAP] Implications of Drug –Polymer Interactions on Time–Temperature–Transformation: A Tool to Assess the Crystallization Propensity in Amorphous Solid Dispersions
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01004 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 6, 2023 Category: Drugs & Pharmacology Authors: Rahul Lalge, N. S. Krishna Kumar, and Raj Suryanarayanan Source Type: research

[ASAP] Synthesis and Evaluation of [ < sup > 11 < /sup > C]MCC950 for Imaging NLRP3-Mediated Inflammation in Atherosclerosis
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00915 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 3, 2023 Category: Drugs & Pharmacology Authors: Uzair S. Ismailani, Ariel Buchler, Nicole MacMullin, Faduma Abdirahman, Myriam Adi, and Benjamin H. Rotstein Source Type: research

[ASAP] Influence of Co-amorphization on the Physical Stability and Dissolution Performance of an Anthelmintic Drug Flubendazole
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00873 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 3, 2023 Category: Drugs & Pharmacology Authors: Nikita A. Vasilev, Alexander P. Voronin, Artem O. Surov, and German L. Perlovich Source Type: research

[ASAP] Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00895 (Source: Molecular Pharmaceutics)
Source: Molecular Pharmaceutics - February 2, 2023 Category: Drugs & Pharmacology Authors: Hanh Thuy Nguyen, Tu Van Duong, and Lynne S. Taylor Source Type: research